Ensayos Clínicos

A Study of Safety, Tolerability, and Clinical Activity of MEDI4736 and Tremelimumab Administered as Monotherapy and in Combination to Subjets with Unresectable Hepatocellular Carcinoma.

Ficha Técnica

Investigador Principal

ENRIQUE FRAGA RIVAS

Promotor

MEDIMMUNE LLC

ESTADO

ACTIVO

DEPARTAMENTO

Aparato Digestivo

Código EudraCT: 2015-001663-39

Número protocolo: D4190C00022

Fecha Inicio: 2015-12-23

Fecha Fin: 2020-11-30